Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage

NCT: NCT07057817 · RECRUITING

NCT IDNCT07057817
StatusRECRUITING
Start Date2026-01-01
Completion2029-12
SponsorRoyal College of Surgeons, Ireland (OTHER)
First posted
Last updated

Brief Summary

The ACHILLS Trial is a multicentre randomised controlled feasibility study comparing partial calcanectomy with and without the use of an antibiotic-impregnated bone graft substitute (Cerament G) for treating calcaneal osteomyelitis, specifically on wound healing rates, re-infection, and overall efficacy in a sample of 30 patients over a one-year period.

Frequently Asked Questions

What is The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage?

The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage is a clinical trial registered under NCT07057817. Current status: RECRUITING.

What is the status of NCT07057817?

The current status of NCT07057817 (The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage) is: RECRUITING.

When did The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage start?

The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage started on 2026-01-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.